Membrane lipids

Membrane lipids are the fundamental structural components of biological membranes, primarily composed of phospholipids, sphingolipids, and sterols (Alberts et al., 2002). They form a semi-permeable bilayer that defines cell boundaries and organizes intracellular compartments, while also serving as a platform for protein-lipid interactions and signal transduction (van Meer et al., 2008). In various diseases, such as cancer and neurodegenerative disorders, the composition and organization of these lipids are often altered, contributing to pathological signaling and membrane instability (Escribá et al., 2008). Many therapeutic agents, particularly antimicrobials like daptomycin and antifungals like amphotericin B, exert their effects by directly interacting with specific membrane lipids to cause pore formation or membrane disruption (Adler et al., 2014). This targeting strategy is crucial for treating resistant infections, although it often presents challenges regarding selectivity between host and pathogen membranes (Zasloff, 2002).

Other names

Cell membrane lipidsPhospholipidsLipid bilayerPlasma membrane lipidsBiological membrane lipids

Drugs targeting membrane lipids typically act by direct binding to specific lipid species (e.g., ergosterol or phosphatidylglycerol), leading to pore formation, membrane depolarization, or physical disruption of the bilayer integrity (StatPearls, 2023). Some agents modulate membrane fluidity or interfere with lipid-mediated signaling pathways, such as the PI3K/Akt pathway, to exert therapeutic effects (Escribá et al., 2008).